You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Inflammatory bowel disease

Therapeutic monitoring of TNF-alpha inhibitors in Crohn’s disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits)

  • HealthTech guidance
  • Reference number: HTG401
  • Published:  17 February 2016
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technologies
  • 3 Clinical need and practice
  • 4 The diagnostic tests
  • 5 Outcomes
  • 6 Considerations
  • 7 Recommendations for further research
  • 8 Implementation
  • 9 Diagnostics Advisory Committee members and NICE project team
  • 10 Sources of evidence considered by the Committee
  • Update information

Update information

Minor changes since publication

December 2025: Diagnostics guidance 22 has been migrated to HealthTech guidance 401. The recommendations and accompanying content remain unchanged.

ISBN: 978-1-4731-7367-5


Previous page 10 Sources of evidence considered by the Committee
Back to top